Divis Laboratories Ltd reported INR265.47M in Ordinary Share Capital for its fiscal quarter ending in March of 2026.





Ordinary Share Capital Change Date
Alaunos Therapeutics USD 2.38M 172K Mar/2026
Aurobindo Pharma INR 580.8M 0 Mar/2026
Dianthus Therapeutics USD 54.58M 11.36M Mar/2026
Divis Laboratories Ltd INR 265.47M 0 Mar/2026
Ionis Pharmaceuticals USD 165.64M 265K Jun/2026
IQVIA Holdings USD 164.6M 2.3M Jun/2026
Lupin INR 457.18M 421K Mar/2026
Moderna USD 391M 2M Sep/2025
Organon & Co USD 262.61M 40K Jun/2026
Revvity USD 111.63M 174K Jun/2026
Tectonic Therapeutic USD 18.83M 92.19K Mar/2026
Tilray USD 116.52M 5.01M Sep/2025
Viatris USD 1.16B 9.19M Jun/2026
Xeris Pharmaceuticals USD 172.56M 6.34M Mar/2026